By Modesto P. Sa-onoy
Dr. Villa makes a startling claim: “Compassionate Drug use does not do anything. Prognosis is dismal. If one survives, (he) will have to go through a long process of rehabilitation and recovery, (but) still requires a high level of medical care and very costly. The quality of life for the most part especially for the older folks is not there.”
Her discourse are all clinical, but we get a glimpse of what happens and perhaps understanding we will be able to appreciate what the doctor does to save lives. Dr. Villa adds the following “commentary” with serious implications, like chasing a dead man’s ghost.
In the “current treatment approach, the Antivirals are being initiated late in the moderate to severe states, phases 3 and 4, wherein there’s hardly any viral replication activities except for the presence of viral debris. We cannot kill something that is already dead or not there anymore. The compassionate use of current antivirals is almost useless, does not improve survival, it may even contribute to the increase in the mortality rate of this group. And it is very costly!!!
“The use of corticosteroids and immune modulators are all given via compassionate use in late phases or stage as well. The use of all these agents is to curtail further production of cytokine and its deleterious effects. It is best given when the damage caused by cytokine storm is not full-blown.
“The use of all these agents in the late Stages is likely more counterproductive therefore not yielding any meaningful benefits. All the best opportunities in decreasing morbidity, preventing progression of disease, and as a result saving lives are in the early stages and early phases of the disease, early and aggressive treatment, where we can decrease viral replication and viral load subsequently mitigating the overwhelming effect of the cytokine storm being the root cause of the patient demise.”
Here’s Dr. Villar’s clincher and what ought to be done: “What is needed is an EARLY TREATMENT APPROACH – the high-risk group with comorbidities should get prophylaxis, be protected, and be treated immediately.
“I practice in the biggest retirement community in the US, age 65 and above, most if not all have pre-existing high-risk conditions. I do see a lot of covid cases. From late August to early September, I have been using EARLY TREATMENT APPROACH. I have been using IVERMECTIN both for prophylaxis and treatment at any stage of the disease. Since then, I have not had any significant morbidity or mortality and NO hospitalization. I stratify patients at presentation or first time of positivity, the high-risk people by age and by comorbidities are treated on same day irrespective of symptoms.
“My Early Treatment Approach consists of:
- Supplements Protocol including Vit D, Vit C, Zinc, Quercetin, Melatonin Vit E, Fish Oil, and others depending on the patient’s needs.
“2. IVERMECTIN both for prophylaxis and treatment in any stage of the disease. I give prophylaxis to the entire family when one member gets infected. I give prophylaxis to my entire staff. I give it to my family and give it to myself for prophylaxis.
“3. Antibiotics like Doxycycline and Azithromycin – found to have synergistic effects with IVM and to prevent secondary Respiratory Tract infection
“4. Monoclonal Antibodies – Bamlanivimab (BAM infusion). I started using this around January 2021 under EUA. This is given to us by the Department of Health, OPC IV infusion. This is given to anybody with qualifying high-risk conditions starting at age 12 (40kg) to adult within 10 days of positivity, mild to moderate cases.
“5. Corticosteroid including Methylprednisolone, Dexamethasone. Prednisone, oral or Injections. I do not hesitate to use them, especially to my Chronic Lungers, even with just mild symptoms on initial presentation.
“6. Anticoagulants, Aspirin, factor Xa inhibitors, Heparinoid SQ 7. Oxygen monitoring.
“8. Easy access to healthcare Providers via Tele-visit either phone or video.
“9. If inflammatory markers can also be tested, it would be good! This further classifies patients as to who has the potential to progress fast and who will need immediate anticoagulation. “Obesity is an independent risk factor both for severity and mortality. Needs anticoagulation right away.
We continue on April 22 with Dr. Villa’s concluding statement.
